LEADER 03613nam 22006254a 450 001 9910830573203321 005 20190813181726.0 010 $a1-280-45054-1 010 $a9786610450541 010 $a0-470-01056-8 010 $a0-470-01055-X 035 $a(CKB)1000000000357456 035 $a(EBL)258946 035 $a(OCoLC)657978312 035 $a(SSID)ssj0000244593 035 $a(PQKBManifestationID)11208841 035 $a(PQKBTitleCode)TC0000244593 035 $a(PQKBWorkID)10170833 035 $a(PQKB)11448429 035 $a(MiAaPQ)EBC258946 035 $a(PPN)162102534 035 $a(EXLCZ)991000000000357456 100 $a20060111d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aSevere dementia /$feditors, Alistair Burns, Bengt Winblad 210 $aChichester, West Sussex, England ;$aHoboken, NJ $cJohn Wiley & Sons$dc2006 215 $a1 online resource (262 p.) 300 $aDescription based upon print version of record. 311 $a0-470-01054-1 320 $aIncludes bibliographical references and index. 327 $aSevere Dementia; Contents; List of Contributors; Introduction; Part 1 Introductory; Chapter 1 Assessment and Diagnosis of Severe Dementia; Chapter 2 Cholinergic and Serotonergic Systems in Severe Dementia; Chapter 3 The Molecular Pathology of Severe Dementia; Part 2 Clinical Features of Severe Dementia; Chapter 4 Cognitive Functions in Severe Dementia; Chapter 5 Behavioural and Psychological Symptoms of Dementia - Agitation; Chapter 6 Depression in Severe Dementia; Chapter 7 Physical Aspects of Severe Alzheimer's Disease; Chapter 8 Clinical Features of Severe Dementia: Staging 327 $aChapter 9 Clinical Features of Severe Dementia: FunctionPart 3 Management; Chapter 10 Drug Treatment: Memantine; Chapter 11 Drug Treatment: Cholinesterase Inhibitors; Chapter 12 Drug Treatment: Treatment of Behavioural and Psychological Symptoms of Dementia with Neuroleptics; Chapter 13 Non-pharmacological Treatment of Severe Dementia: An Overview; Chapter 14 Non-pharmacological Treatment of Severe Dementia:the Seattle Protocols; Chapter 15 Care by Families for Late Stage Dementia; Chapter 16 Person-centred Care for People with Severe Dementia 327 $aChapter 17 Palliative Care in Patients with Severe DementiaChapter 18 Narrative Ethics and Ethical Narratives in Dementia; Chapter 19 Health Economics of Severe Dementia; Index 330 $aThe later stages of dementia are as important, if not more so, as the earlier stages, since they harbour unique characteristics and events, which profoundly affect the lives of patients and their carers. Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will delay disease progression. Severe Dementia is the first book to focus exclusively on severe dementia. It addresses both the clinical featur 606 $aDementia 606 $aDementia$xChemotherapy 606 $aDementia$xTreatment 615 0$aDementia. 615 0$aDementia$xChemotherapy. 615 0$aDementia$xTreatment. 676 $a616.83 676 $a616.831061 701 $aBurns$b Alistair S$01701535 701 $aWinblad$b Bengt$01342854 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830573203321 996 $aSevere dementia$94085342 997 $aUNINA